William A. Sullivan
2013
In 2013, William A. Sullivan earned a total compensation of $968.2K as Chief Financial Officer and Treasurer at Merrimack Pharmaceuticals, a 14% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $101,441 |
---|---|
Option Awards | $568,170 |
Salary | $284,639 |
Other | $13,948 |
Total | $968,198 |
Sullivan received $568.2K in option awards, accounting for 59% of the total pay in 2013.
Sullivan also received $101.4K in non-equity incentive plan, $284.6K in salary and $13.9K in other compensation.
Rankings
In 2013, William A. Sullivan's compensation ranked 6,770th out of 12,286 executives tracked by ExecPay. In other words, Sullivan earned more than 44.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,770 out of 12,286 | 45th |
Division Manufacturing | 2,392 out of 4,612 | 48th |
Major group Chemicals And Allied Products | 719 out of 1,462 | 51st |
Industry group Drugs | 527 out of 1,156 | 54th |
Industry Pharmaceutical Preparations | 419 out of 890 | 53rd |
Source: SEC filing on March 27, 2015.
Sullivan's colleagues
We found four more compensation records of executives who worked with William A. Sullivan at Merrimack Pharmaceuticals in 2013.
2013
Robert Mulroy
Merrimack Pharmaceuticals
Chief Executive Officer
2013
Ulrik Nielsen
Merrimack Pharmaceuticals
Chief Scientific Officer
2013
William McClements
Merrimack Pharmaceuticals
Head of Corporate Operations
2013
Edward Stewart
Merrimack Pharmaceuticals